APP and Alzheimer disease: Several studies have shown that with dysfunction in the LC-NA system in Alzheimer’s disease, there is a loss of endogenous anti-inflammatory effects and of the capacity for amyloid beta peptide (Aβ) degradation and clearance1 61 62 that is normally promoted by NA.